MASLD进展的血蛋白质组学:从功能分析洞察到驱动新治疗方案的开发
本文综述了MASLD与MASH(重点为纤维化)的最新血液蛋白质组学研究,并对失调蛋白进行功能富集分析以整合蛋白质通路与相互作用。尽管方法学和循环蛋白数量差异大,上调与下调蛋白谱仍呈一致模式,分别对应补体激活与高密度脂蛋白重塑等过程。作者指出血液蛋白质组学有助于阐明机制和发现无创生物标志物,但全球推广、分析技术优化和大型纵向研究等挑战仍待解决。
要点
- 血液蛋白质组学在MASLD/MASH中显示一致的上调与下调蛋白模式。
- 下调蛋白主要关联高密度脂蛋白重塑,上调蛋白主要关联补体激活。
- 鉴定出的蛋白家族涉及免疫、细胞黏附与迁移、应激细胞糖蛋白配体及含Sushi结构域蛋白。
核心结论
- 应用前沿方法研究MASH血液蛋白质组可促进疾病机制阐明和最佳无创生物标志物的识别。
- 未来研究仍需解决结果全球推广、分析技术优化和实施大型纵向研究等挑战,以理解晚期疾病发生的分子机制。
研究设计与样本
- 本研究为综述,系统回顾MASLD和MASH(重点为纤维化)的最新血液蛋白质组学研究。
- 并通过功能富集分析整合失调蛋白,分析蛋白质通路与相互作用。
主要发现
- 尽管方法学和循环中检测蛋白数量存在显著差异,患者血液中降低或升高的蛋白列表呈现一致模式。
- 下调蛋白相关生物学过程为高密度脂蛋白重塑,上调蛋白相关生物学过程为补体激活。
- 鉴定出的蛋白家族包括免疫系统、细胞黏附与迁移相关蛋白,以及应激细胞表达的糖蛋白配体和含Sushi结构域蛋白。
临床怎么用
- 原文未据此给出推荐。
局限性
- 方法学和循环中检测蛋白数量存在显著差异。
- 结果在全球范围内的推广仍是待解决问题。
- 分析技术有待优化。
- 需实施大型纵向研究以深入理解晚期疾病发生的分子机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading chronic liver disease worldwide, with alarming prevalence reaching epidemic proportions. AIMS AND METHODS: The objective of this study is to provide a comprehensive review of the latest blood proteomics studies on MASLD and metabolic dysfunction-associated steatohepatitis (MASH), with emphasis on fibrosis. Furthermore, our objective is to conduct an analysis of protein pathways and interactions by integrating proteomics data using functional enrichment analysis of the deregulated proteins. RESULTS: Notwithstanding the considerable discrepancies in the methodology and the number of proteins examined in the circulation, the analysis reveals a consistent pattern among the list of proteins that are decreased or increased in the blood of the affected patients. The relevant biological processes (BP) associated with down- and upregulated proteins are high-density lipoprotein remodelling and complement activation, respectively. The protein families identified include not only those expected to be involved in the immune system and cell adhesion and migration but also ligands of glycoproteins expressed in cells that have been subjected to stress and proteins containing the Sushi domain. CONCLUSIONS: The application of cutting-edge methodologies to investigate the blood proteome in MASH is yielding insights that facilitate the elucidation of disease mechanisms and the identification of optimal noninvasive biomarkers. However, several challenges remain to be addressed in future research, including the generalisation of results on a global scale, the optimisation of analytical technologies and the implementation of large longitudinal studies to gain insights into the molecular mechanisms that underpin the development of advanced disease.
引用
- Pirola CJ, Fernández Gianotti T, Sookoian S, et al. The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions. Aliment Pharmacol Ther. 2025. PMID: 39744897. doi:10.1111/apt.18468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。